Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values.

Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values.

Publication date: Jan 08, 2025

The study aimed to investigate the association between quantitative T-SPOT. TB values and the risk of incident and prevalent tuberculosis disease (TBD), identify risk factors, and evaluate test accuracy. This retrospective cohort study followed patients tested consecutively with T-SPOT. TB at Aarhus University Hospital from 2010 to 2017, with follow-up for incident TBD through 2022. Data on demographics, comorbidities, medications, and TB status were collected from patient records and national registries. Cox proportional hazard models with restricted cubic splines assessed the risk of incident TBD (occurring ≥3 months post-test) by quantitative spot counts. Cox and log-binomial regressions identified risk factors for incident and prevalent TBD (occurring between 3 months before and after the test). Sensitivity, specificity, and predictive values assessed test accuracy. T-SPOT. TB was the index test, and microbiologically and/or clinically confirmed TBD was the reference standard. Among 8542 individuals with complete follow-up, 59 developed incident TBD over 67 456 person-years. Among 9014 individuals tested once, 162 had prevalent TBD at the time of testing. The risk of incident TBD increased with higher spot counts, plateauing for tests with more than ten spots. The strongest risk factors for both incident and prevalent TBD were categorical T-SPOT. TB results: compared with negative tests (≤4 spots), adjusted hazard ratios for incident TBD were 5. 0 (95% CI: 1. 9-13. 1) for borderline (5-7 spots) and 8. 0 (95% CI: 4. 0-15. 7) for positive tests (≥8 spots). Adjusted risk ratios for prevalent TBD were 14. 9 (95% CI: 7. 7-28. 9) for borderline and 35. 6 (95% CI: 21. 4-59. 2) for positive tests. Sensitivities for incident and prevalent TBD were 54. 0% (95% CI: 39. 3-68. 2%) and 78. 4% (95% CI: 71. 3-84. 5%), respectively. Specificities were 84. 8 (84. 0-85. 4) and 83. 7 (82. 9-84. 4), respectively. Incident TBD risk increases with T-SPOT. TB values but plateaus beyond 10 spots. Borderline and positive T-SPOT. TB results are strongly linked to TBD risk.

Concepts Keywords
Diagnostic Epidemiology
Microbiologically Memory T-cell response
Tuberculosis Mycobacterium tuberculosis
Tuberculosis

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK 2 2-bis(4-hydroxy-3-tert-butylphenyl)propane
drug DRUGBANK Pentaerythritol tetranitrate
pathway REACTOME Release
disease IDO assay
disease IDO cell

Leave a Comment

Your email address will not be published. Required fields are marked *